Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Issue: Reiterate the importance of animal models in medical research.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Issue: Support unique mission of academic medicine.

H.R. 4502 Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Draft Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022

Presidents FY 2022 Budget Request
Issues: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, Ebola and emerging special pathogens and public health preparedness programs. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Support animal research and oppose efforts to increase burden on researchers unnecessarily. Support discussions on Advanced Research Projects Agency for Health and ensure investment does not supplant NIH funding. Oppose arbitrary restrictions on specific types of research. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Racial and Ethnic Approaches to Community Health program (REACH), Prevention Research Centers, hospital-based and community violence interventions, and for research on gun violence. Support funding for Department of Education and federal student aid. Support funding to combat opioid epidemic and for new curricular materials. Support emergency funding and exemptions from discretionary spending caps. Support extensions of the period of disbursement for multi-year NIH grants. Support ongoing investment in public health infrastructure. Support funding for maternal health and mortality improvement initiatives. Support expansion of CDC-supported genomic sequencing. Support increased funding for Telehealth Resource Centers.
Issue: Support investment in nondefense discretionary spending, including ample funding allocations for Labor-HHS-Education.

H.R. 4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Draft Senate FY 2022 Commerce, Justice, Science, and Related Agencies Appropriations Act
Presidents FY 2022 Budget Request
Issues: Support funding for the National Science Foundation (NSF)

H.R. 4502 Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022

S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Presidents FY 2022 Budget Request
Draft FY2023 Presidents Budget Request
Issues: Support funding for Veterans Affairs medical research, research infrastructure, information technology, and community care. Oppose restrictions on use of canines in VA medical research. Oppose VA research funding rescissions.
P.L. 117-43 Extending Government Funding and Delivering Emergency Assistance Act
Issue: Support continued funding of the federal government and timely completion of the FY 2022 appropriations process. Support extensions of the period of disbursement for multi-year NIH grants.

P.L. 117-2, the American Rescue Plan
Issue: Encourage agencies to implement funding relief for federal research agencies, new COVID-19 research, funding for data science, CDC-supported genomic sequencing, public health data modernization, investment in public health infrastructure, testing, contact tracing, vaccine development and distribution. Support funding for provider relief fund. Support supplemental funding for HRSA workforce programs, the National Health Service Corps, and programs addressing the mental health and well-being of health care providers. Support funding for increased FMAP for new states to expand Medicaid. Support funding for COBRA premium assistance. Support expanded subsidies in the ACA marketplaces. Support extension of postpartum Medicaid and CHIP coverage for 12 months. Support extension of Medicare sequester.

Issue: Support additional Medicare funding for graduate medical education and oppose any reductions

Issue: Support additional Medicare funding for graduate medical education for addiction medicine, addiction psychiatry, and pain medicine residency programs

H.R. 869, Research Investment to Spark the Economy Act
S. 289 Research Investment to Spark the Economy (RISE) Act
Issue: Support emergency funding to provide relief for federal research agencies and to extend administrative flexibilities.

Issue: Support emergency funding for NIH and NSF to mitigate pandemic related disruptions.

American Jobs Plan
American Families Plan
H.R. 5376, Build Back Better Act
Draft Senate Reconciliation Legislation
Issue: Support funding for pandemic resilience, funding for research and development, and VA hospital infrastructure. Support increased Medicare support for physician training and the physician workforce. Support maximum funding for public health and health care preparedness. Support valid, inclusive data collection. Support funding for research infrastructure and research recovery. Support funding for broadband access and other physical infrastructure. Support funding for capital projects at hospitals to enhance preparedness and expand ICU capacity. Support funding for grants between public health departments and academic medical centers. Support funding for Teaching Health Center Graduate Medical Education and Childrens Hospital Graduate Medical Education.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), Natl Economic Council (NEC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Issue: Educate Congress regarding technology transfer and the importance of the Bayh-Dole Act to the US patent system.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

Draft Higher Education Act Reauthorization
Issues: Support affordable income driven repayment plans for borrowers. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF) and elimination of GradPLUS loans.

H.R. 6720, Student Loan Forgiveness for Frontline Health Workers Act
Issue: Support loan forgiveness for COVID-19 health workers.

Issue: Support a change in the Higher Education Emergency Relief Fund formula to better include independent medical students.

S. 847-Student Loan Tax Elimination Act
Issue: Support the elimination of origination fees on federal student loans.

Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice.

H.R. 801, the Expanding Medical Education Act
H.R. 5376, Build Back Better Act
Issue: Support grants to create, expand, and support regional medical campuses.

H.R. 5376, Build Back Better Act
Issue: Support scholarships for disadvantaged students entering medical school.

Issue: Educate Congress on the role academic medicine can serve with the Commission on the Social Status of Black Men and Boys

H.R. 4631, the Protecting Our Students by Terminating Graduate Rates that Add to Debt Act
Issue: Support the reinstatement of Federal Direct Subsidized Loans for graduate students.

Issue: Educate Congress on medical licensing exams (USMLE/COMLEX) and how they are utilized in residency applications.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Education - Dept of, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.

Draft Graduate Medical Education Reform Act
Issue: Support increased funding for the National Health Service Corps, Teaching Health Center GME, and National Disaster Medical Service (NDMS) demonstration pilot. Support increased Medicare support for Graduate Medical Education/physician training.

Issues: Educate Congress and the administration about academic medicines response to the opioid epidemic. Support funding for training on substance use disorders, pain management, and safe prescribing practices. Support suspension of DATA waivers and new guidelines to expand access to buprenorphine. Support continuation of telehealth flexibilities allowing authorized practitioners to prescribe buprenorphine.

H.R. 1384/ S.445 Mainstreaming Addiction Treatment (MAT) Act of 2021
Issue: Support suspension of waiver requirement for certain providers to prescribe buprenorphine.

P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels.

Issue: Support high-quality affordable health insurance. Support programs and funds for safety-net providers.

Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including not providing 340B discounts on covered drugs purchased at community pharmacies.

H.R. 3203/S. 773
Issue: Support policy to allow 340B DSH hospitals to remain eligible to participate in the program throughout the current public health emergency even if their DSH adjustment falls below the current threshold due to changes in payor mix as a result of the COVID-19 pandemic.

Issue: Oppose insurance plans that do not meet Affordable Care Act requirements.

Issue: Oppose efforts to direct HHS to update the Medicare.gov Care Compare website.

Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued.

Issue: Support the ongoing refinement of the two new mandatory alternative payment models, the Radiation Oncology Model and End-stage Renal Disease Treatment Choices Model, to better incentivize high-quality care for all patients.

H.R. 4128/ S. 2209 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021
Issue: Educate Congress on development of Laboratory Developed Tests and impact of burdensome regulation on patients access to care at academic medical centers.

Issue: Development of Enhanced Primary Care Pilot Act proposal

Draft Health Equity and Accountability Act
Issue: Support programs to improve health equity and address social determinants of health.

Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity.

H.R. 2503 Social Determinants Accelerator Act of 2021
Issue: Support grants to address social determinants of health

Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health.

Issue: Support maternal health initiatives to expand coverage for postpartum women and expand demonstration project grants.

H.R. 959 Black Maternal Health Momnibus Act of 2021
S. 1695 / H.R. 4387 Maternal Health Quality Improvement Act
S. 1491/ H.R. 769 Rural MOMs Act
H.R. 4387 Maternal Health Quality Improvement Act of 2021
H.R. 5376, Build Back Better Act
Issue: Support legislative efforts to improve maternal health and reduce rates of maternal mortality, including the Momnibus.

Issue: Support policies to promote firearm safety, universal background checks, violence prevention programs, extreme risks protection orders, child access safety laws, and reinstating assault weapons ban.

Issue: Support funding for Community Violence Interventions/ Hospital Based Violence Intervention Programs

S. 610/H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act
Issue: Support grants directed at improving clinician burnout and well-being.

Issue: Provide feedback on implementation of the Provider Relief Fund. Support extension for use of PRF funds.

Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs, including delaying recoupment of MAAP loans.

Issue: Support extension of public health emergency declaration.

Issue: Provide feedback on COVID-19 and pandemic response centers of excellence legislation.

Issue: Provide information on COVID-19 long haulers clinical care.

Issue: Provide feedback on draft pandemic preparedness legislation

Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students and academic medical centers in administering COVID vaccines.

Issue: Urge establishment and implementation of robust national COVID-19 testing strategy and functional and transparent supply chain.

Issue: Support mask requirements on public transportation.

Issue: Provide input on COVID-19 vaccination requirements for health care workers.

H.R. 708, S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout the COVID-19 public health emergency

S. 674 Public Health Infrastructure Saves Lives Act
Issue: Support investments in core public health infrastructure.

Issue: Support ensuring patients are put first and that conscience protections align with medical professionalism standards.

Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021.

Issue: Support promotion of data sharing and clinical trials results reporting.

H.R. 791/ S. 236 - Tracking COVID-19 Variants Act
Issue: Support expansion of CDC-supported genomic sequencing, including at academic medical centers.

Issue: Provide feedback on draft Cures 2.0 legislation, including on Public health, patients and caregivers, FDA, CMS, and research, and respond to request for information on ARPA-H.

Issue: Promote strategies to strengthen the health, public health, and research workforces.

H.R. 3671 - Doctors of Community Act
Issue: Discuss authorization of the Teaching Health Center Graduate Medical Education program.

Issue: Provide guidance on the implementation of the No Surprises Act.

Issue: Provide feedback on proposed modifications to the HIPAA privacy rule.

H.R. 5035, S. 2982 Child Suicide Prevention and Lethal Means Safety Act
Issue: Support legislation to provide grants to improve suicide prevention and lethal means safety.

Issue: Encourage actions to improve COVID-19 response and future pandemic preparedness including improved federal coordination, greater supply chain redundancy, and investments in public health and health care human resources.

Issue: Inform about academic medicines efforts in UME, GME, and CME on caring for older adults.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), White House Office, Federal Emergency Management Agency (FEMA), Office of the Vice President of the United States, Homeland Security - Dept of (DHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

H.R. 6, The American Dream and Promise Act of 2021
H.R. 1177, S. 348 US. Citizenship Act
S. 264, Dream Act of 2021
H.R. 5376, Build Back Better Act
Issue: Support policies allowing undocumented students to attend U.S. medical schools and graduate medical education. Support Dreamer eligibility for federal student loans.

Issue: Support retention of DACA Executive Action

H.R. 3541, S. 1810, Conrad State 30 and Physician Access Reauthorization Act
Issue: Support reauthorization and expansion of the Conrad 30 program, and improvements to physician immigration

Issue: Support policies to ensure timely and predictable processing for immigration of academic medicine community

Issue: Support extending duration of stay for physicians on visas during the COVID pandemic, expediting change of status and visa renewals, and expedite visa approvals for medical residents entering the country. Support efforts to ensure international medical residents can enter the U.S.

Issue: Oppose policies limiting entry of medical students, residents, researchers, and health professionals to the U.S. on the F-1, J-1, and H-1B visas.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), White House Office, Executive Office of the President (EOP), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

Draft Cures 2.0 Legislation
Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.

Issue: Support clinical trials diversity.

Issue: Support prompt establishment of the Research Policy Board and implementation of the additional reform efforts required by Section 2034 of the 21st Century Cures Act (P.L. 114-255).

Issue: Support ethical use of fetal tissue in medical research.

Issue: Participate in OSTP/NIH listening sessions on ARPA-H.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office, Office of Science & Technology Policy (OSTP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issue: Support policies to close the Medicaid coverage gap, including through ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers.

H.R. 2256 / S. 834, Resident Physician Shortage Reduction Act of 2021
Issue: Support additional Medicare funding for graduate medical education

S. 1438 Opioid Workforce Act
H.R. 3441 Substance Use Disorder Workforce Act
Issue: Support additional Medicare funding for graduate medical education for addiction medicine, addiction psychiatry, and pain medicine residency programs

S.1893, Draft House bill Rural Physician Workforce Production Act
Issue: Oppose legislation redesigning Medicare GME payment formulas that reduce current DGME/IME payments to teaching hospitals

H.R. 5376, Build Back Better Act
Issue: Support additional Medicare funding for graduate medical education slots.

Issue: Support efforts to increase physician workforce diversification through novel, targeted scholarship programs.

Issue: Support protection of the 340B Drug Pricing Program in the budget reconciliation package

Issue: Support for 12-months continuous coverage for children on Medicaid and CHIP

Issue: Support strengthening the ACA and address the Medicaid coverage gap

Rural-Urban Physician Workforce Act
Issue: Support improvements to Rural Training Track programs.

Issue: Provide feedback to CMS on its proposed distribution of the 1,000 new GME slots authorized be the Consolidated Appropriations Act, 2021 as described in the 2022 Inpatient Prospective Payment System (IPPS) proposed rule. Support CMS adopting alternative 2 with modifications to allow for more than 1.0 FTE per hospital.

Issue: Support Medicare Graduate Medical Education (GME) per resident amount and cap-setting technical corrections and administrative relief.

Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments

Issue: Oppose reduction of Medicare GME/IME payments

Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.

Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.

Issue: Oppose Medicare hospital cuts

Issue: Oppose overly burdensome Medicaid GME transparency language.

Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.

Issue: Educate Congress on role of academic medicine as it relates to price transparency or disclosure initiatives

Draft, Improving Seniors Timely Access to Care Act
Issue: Support protecting patients from delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program and providing program oversight and transparency

Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs

HHS Rebate Rule
Medicare Part D benefit re-design
Issue: Support policies to reduce prescription drug prices

Issue: Support implementation of the 21st Century Cures Act (Cures) interoperability and health data sharing provisions.

Issue: Support changes and improvements to the Medicare Shared Savings Program.

Issue: Support necessary changes and improvements to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)

Issue: Support expansion of Medicaid and CHIP coverage for postpartum women.

H.R. 315 Medicare Sequester COVID Moratorium Act
S. 748 Medicare Sequester Relief Act
H.R. 1868 To prevent across-the-board direct spending cuts, and for other purposes.
Issue: Support extension of Medicare sequester moratorium.

Issue: Support clearing the PAYGO scorecard to avoid another Medicare sequester due to the use of reconciliation to pass the American Rescue Plan Act.

Issue: Oppose use of extended Medicare sequester and repurposing of unused Provider Relief Fund as a financing mechanism for bipartisan infrastructure package.

Issue: Support congressional extension of 3.75% temporary increase in the Medicare physician fee schedule that Congress provided in the Consolidated Appropriations Act, 2021 to avoid payment cuts due to budget neutrality requirements.

Issue: Oppose efforts by states to impose work or other community engagement activities as a requirement for continued Medicaid eligibility or coverage for certain Medicaid beneficiaries.

Issue: Support making permanent the CMS policy allowing teaching physicians to provide supervision via real-time, interactive audio/video technology to meet resident supervision requirements.

Issue: Support making permanent the interim final rule that allows hospitals that unknowingly trigger their Medicare GME caps and per resident amounts to not have that happen and instead retain the ability to build a new resident cap / PRA so long as the cap / PRA is not above a minimum amount.

Issue: Support CMS introducing new regulations to make permanent the interim final rule that ensures teaching hospitals that increased their number of inpatient beds to accommodate the surge in patients during the public health emergency to not have their Indirect Medical Education (IME) payments reduced by CMS.

Issue: Oppose CMS hospital price transparency rule.

Issue: Oppose site-neutral expansion to excepted off-campus provider-based departments (PBDs).

Issue: Support waiving budget neutrality requirements associated with the E/M code changes or temporarily holding harmless physicians and other health care professionals.

Issue: Oppose finalizing proposed rule for Medicare Coverage of Innovative Technology (MCIT) and definition of reasonable and necessary.

Issue: Oppose enforcement of linking Medicare Conditions of Participation (CoP) compliance with requiring that hospitals report 38 COVID-19 related measures.

Issue: Support continuation of the 3-Day Skilled Nursing Facility (SNF) Stay waiver after the conclusion of the COVID-19 public health emergency.

Issue: Oppose policy of incorporating revenue distinctions into the Medicare Shared Savings Program.

Issue: Support permanent extension of Medicare telehealth waivers, including removing patient location restrictions and rural site requirements, allowing payment for audio-only services, and reimbursing providers for telehealth services as services delivered in-person.

Issue: Support extension of Hospital at Home program waiver of 24/7 nursing requirement.

Issue: Support permanent extension of current Covid telehealth flexibilities

HR 1332, the Telehealth Modernization Act
Issue: Support efforts to expand patient access to telehealth

HR 1397, the Telehealth Improvement for Kids Essential Services Act
Issue: Support providing states with guidance to increase telehealth access in Medicaid and CHIP

Issue: Support efforts to improve access to childrens mental health care

HR 5035, The Child Suicide Prevention and Lethal Means Safety Act
Issue: Support expansion of training for health professionals to prevent self-harm or suicide

Issue: Support funding to support hospital-based violence intervention programs and community violence interventions

S. 2061 Telemental Health Care Access Act
Issue: Support policy to remove requirement for Medicare beneficiaries to be seen in-person every six months for telehealth visits for mental health services

Issue: Support creation of new Medicare outpatient IME payment in addition to existing Medicare IME payment inpatient methodology. Oppose policies to create IME payments for outpatient services while remaining budget neutral.

Issue: Support efforts to reverse cuts in Medicare OPPS reimbursements to hospitals for drugs acquired under the 340B program.

Issue: Support extension of 24/7 nursing care waiver for Acute Hospital Care at Home program.

Draft Value in Health Care Act
Issue: Support changes to alternative payment models (APMs) to increase participation in value-based health programs and promote quality care and improved health outcomes.

H.R. 3746 Accountable Care in Rural America Act
Issue: Support improving the benchmarking process for the Medicare Shared Savings Program (MSSP) to ensure that all ACOs have an equal opportunity to share in savings regardless of their geographic location.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Issue: Support reducing administrative and regulatory burden on scientists and research institutions.

S.1169 - Strategic Competition Act of 2021
S.1260 - United States Innovation and Competition Act of 2021
H.R.2731 -Endless Frontier Act
H.R.2225 - National Science Foundation for the Future Act
Issue: Support efforts to promote research integrity, address harassment in science, and address potential for foreign influence in science using a balanced approach, including stakeholder engagement from institutions of higher education. Oppose Committee on Foreign Investment in the United States (CFIUS) review of proposed gifts and contracts to U.S. research institutions.

Issue: Urge Congress to let science lead investigations of COVID-19 origins.

Issue: Educate Congress on uses of gain of function research.

Issue: Support the use of a competitive peer review process for federal research grants and programs.

Issue: Explore opportunities to improve research with cannabinoids.

Issue: Urge extension of COVID-19 related administrative flexibilities.

HR 869 / S 289, Research Investment to Spark the Economy Act
Issue: Support research recovery at federal science agencies due to COVID-19 pandemic.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships. Educate Congress on the national physician workforce shortages impact on VA.

Issue: Support maintaining VA medical services in conjunction with VA community care.

Issue: Provide feedback on VA Conflict of Interest and GME timekeeping policies.

Draft VA Infrastructure Powers Exceptional Research Act of 2021
Issue: Support increased investments in IT and physical research infrastructure for the VA research program; Support Paperwork Reduction Act exemption for VA researchers; support hiring flexibilities for VA research personnel; support dedicated time for research for physician scientists in the VA research program; support dual appointments with academic affiliates.

Issue: Provide feedback on draft veteran's pro bono medical exams legislation.

17. House(s) of Congress and Federal agencies Check if None

Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Issue: Educate Congress on the community benefit of not-for-profit hospitals and the importance of preserving their tax-exempt status.

Issue: Support the elimination of taxes on non-tuition student scholarship and grant aid.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, Internal Revenue Service (IRS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

Issue: Support delay in implementation of emergency temporary standard (ETS) for COVID-19, and to delay the deadline for comment. Support modifications to the ETS that reflect the current state of science and practicalities of delivering patient care.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Occupational Safety & Health Administration (OSHA), Labor - Dept of (DOL)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes